{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:58:31Z","timestamp":1788479911240,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.yjmcc.2009.09.001","type":"journal-article","created":{"date-parts":[[2009,9,13]],"date-time":"2009-09-13T08:08:32Z","timestamp":1252829312000},"page":"461-467","source":"Crossref","is-referenced-by-count":120,"title":["Extracellular matrix remodeling in atrial fibrosis: Mechanisms and implications in atrial fibrillation"],"prefix":"10.1016","volume":"48","author":[{"given":"Jason","family":"Pellman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2009.09.001_bib1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin\u2013angiotensin\u2013aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.hrthm.2008.01.023","article-title":"Pharmacotherapy for atrial arrhythmias: present and future","volume":"5","author":"Mazzini","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib3","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/CIRCULATIONAHA.108.823179","article-title":"Apples and oranges: comparing antiarrhythmic drugs and catheter ablation for treatment of atrial fibrillation","volume":"118","author":"Callans","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/bmb\/ldn046","article-title":"Treatment of atrial fibrillation","volume":"88","author":"Bajpai","year":"2008","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00004872-200405000-00024","article-title":"Tranilast attenuates myocardial fibrosis in association with suppression of monocyte\/macrophage infiltration in DOCA\/salt hypertensive rats","volume":"22","author":"Kagitani","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00029330-200801010-00008","article-title":"Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs","volume":"121","author":"Yang","year":"2008","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib11","first-page":"575","article-title":"Left atrial ultrastructure in mitral valvular disease","volume":"89","author":"Thiedemann","year":"1977","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib12","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","article-title":"Histological substrate of atrial biopsies in patients with lone atrial fibrillation","volume":"96","author":"Frustaci","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jtcvs.2008.05.015","article-title":"Persistent atrial fibrillation in a goat model of chronic left atrial overload","volume":"136","author":"Remes","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.RES.0000129579.59664.9d","article-title":"Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1","volume":"94","author":"Verheule","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.CIR.82.3.792","article-title":"Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study","volume":"82","author":"Sanfilippo","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib16","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1161\/01.CIR.0000066915.15187.51","article-title":"Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation","volume":"107","author":"Verheule","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.carpath.2007.12.003","article-title":"Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation","volume":"17","author":"Knackstedt","year":"2008","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1046\/j.1460-9592.2003.t01-1-00234.x","article-title":"Electrophysiological remodeling in human atrial fibrillation","volume":"26","author":"Van Wagoner","year":"2003","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib19","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000092568","article-title":"Role of connexins in atrial fibrillation","volume":"42","author":"Dhein","year":"2006","journal-title":"Adv. Cardiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000095501","article-title":"Fibrosis of collagen I and remodeling of connexin 43 in atrial myocardium of patients with atrial fibrillation","volume":"107","author":"Luo","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0248-4900(02)00018-7","article-title":"Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40","volume":"94","author":"Dhein","year":"2002","journal-title":"Biol. Cell"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.0000109501.47603.0C","article-title":"Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure","volume":"109","author":"Cha","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2008.02.072","article-title":"Molecular genetics of atrial fibrillation","volume":"52","author":"Tsai","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib25","doi-asserted-by":"crossref","first-page":"H2324","DOI":"10.1152\/ajpheart.00581.2004","article-title":"Loss of atrial contractility is primary cause of atrial dilatation during first days of atrial fibrillation","volume":"287","author":"Schotten","year":"2004","journal-title":"Am. J. Physiol., Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib26","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.RES.0000172556.05576.4c","article-title":"Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice","volume":"96","author":"Li","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pbiomolbio.2008.02.019","article-title":"Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria","volume":"97","author":"Eckstein","year":"2008","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","article-title":"Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation","volume":"17","author":"Young","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib29","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","article-title":"Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion","volume":"35","author":"Sun","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0895-7061(02)03199-0","article-title":"Aldosterone-induced cardiac damage: focus on blood pressure independent effects","volume":"16","author":"Schmidt","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib32","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation","volume":"273","author":"Silvestre","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib33","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/en.141.10.3871","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1749-6632.1960.tb20077.x","article-title":"Studies on the metabolic effects of spironolactone in man","volume":"88","author":"Hood","year":"1960","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib36","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib37","first-page":"292","article-title":"A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure","volume":"19","author":"Shehab","year":"2008","journal-title":"Cardiovasc. J. Afr."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib38","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/eurheartj\/ehi478","article-title":"Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction","volume":"26","author":"Milliez","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib39","doi-asserted-by":"crossref","first-page":"16633","DOI":"10.1074\/jbc.M109.008748","article-title":"Aldosterone stimulates elastogenesis in cardiac fibroblasts via mineralocorticoid receptor-independent action involving the consecutive activation of Galpha13, c-Src, the insulin-like growth factor-I receptor, and phosphatidylinositol 3-kinase\/Akt","volume":"284","author":"Bunda","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FJC.0b013e318033dfd4","article-title":"Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation","volume":"49","author":"Nishioka","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1345\/aph.1E306","article-title":"Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure","volume":"39","author":"Barnes","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib42","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jjcc.2008.07.018","article-title":"Valsartan improves l-NAME-exacerbated cardiac fibrosis with TGF-beta inhibition and apoptosis induction in spontaneously hypertensive rats","volume":"52","author":"Akashiba","year":"2008","journal-title":"J. Cardiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib44","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0735-1097(03)00464-9","article-title":"Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation","volume":"41","author":"Kumagai","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib45","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa0805710","article-title":"Valsartan for prevention of recurrent atrial fibrillation","volume":"360","author":"Disertori","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-008-9803-8","article-title":"Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats","volume":"317","author":"Zhao","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.hrthm.2007.12.010","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure","volume":"5","author":"Shimano","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63363-9","article-title":"Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death","volume":"165","author":"Xiao","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.RES.86.5.571","article-title":"Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart","volume":"86","author":"Nakajima","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib50","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"97","author":"Paradis","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00788631","article-title":"Myocardial angiotensin receptor type 1 gene expression in a rat model of cardiac volume overload","volume":"92","author":"Bauer","year":"1997","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib52","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.107.748053","article-title":"Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences","volume":"117","author":"Burstein","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib54","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1073\/pnas.0811706106","article-title":"An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo","volume":"106","author":"Lymperopoulos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1160\/TH04-08-0522","article-title":"Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors","volume":"93","author":"Kassiri","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib56","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2559.2006.02398.x","article-title":"Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy","volume":"48","author":"Herpel","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.RES.0000258428.09589.1a","article-title":"Contrasting gene expression profiles in two canine models of atrial fibrillation","volume":"100","author":"Cardin","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib58","doi-asserted-by":"crossref","first-page":"H982","DOI":"10.1152\/ajpheart.00151.2005","article-title":"Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis","volume":"289","author":"Bouzeghrane","year":"2005","journal-title":"Am. J. Physiol., Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib59","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.hrthm.2007.03.034","article-title":"Increased expression of extracellular matrix proteins in rapid atrial pacing-induced atrial fibrillation","volume":"4","author":"Lin","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2009.05.005","article-title":"Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling","author":"Ramirez","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib61","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib62","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.amjcard.2005.08.073","article-title":"Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation","volume":"97","author":"Mukherjee","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib63","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cardfail.2008.07.229","article-title":"Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure","volume":"14","author":"Moe","year":"2008","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S1431927608080021","article-title":"Cell patterning: interaction of cardiac myocytes and fibroblasts in three-dimensional culture","volume":"14","author":"Baudino","year":"2008","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.hrthm.2008.10.018","article-title":"Diacylglycerol kinase zeta inhibits G(alpha)q-induced atrial remodeling in transgenic mice","volume":"6","author":"Hirose","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib66","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3181\/0811-RM-321","article-title":"A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart","volume":"234","author":"Zaman","year":"2009","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.yjmcc.2009.09.001_bib67","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2009.09.001_bib68","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.yjmcc.2008.11.017","article-title":"Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes","volume":"46","author":"Recchia","year":"2009","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282809003770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282809003770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T03:37:44Z","timestamp":1739331464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282809003770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0022282809003770"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2009.09.001","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}